BioCardia Files 8-K on Equity Sales and Other Events
Ticker: BCDA · Form: 8-K · Filed: Apr 23, 2025 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, 8-k, filing
TL;DR
BioCardia sold unregistered equity, watch for dilution.
AI Summary
On April 22, 2025, BioCardia, Inc. filed an 8-K report detailing unregistered sales of equity securities. The company also reported other events and filed financial statements and exhibits. The filing does not specify the exact number of securities sold or the dollar amounts involved.
Why It Matters
This filing indicates potential dilution for existing shareholders due to unregistered equity sales, which could impact the stock price.
Risk Assessment
Risk Level: medium — Unregistered equity sales can lead to dilution and signal potential financial distress or a need for capital.
Key Players & Entities
- BioCardia, Inc. (company) — Registrant
- April 22, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-38999 (filing_number) — SEC File Number
- 320 Soquel Way Sunnyvale, California 94085 (address) — Principal executive offices
FAQ
What type of equity securities were sold?
The filing states 'Unregistered Sales of Equity Securities' but does not specify the type of securities sold.
How many equity securities were sold?
The filing does not provide the exact number of equity securities sold.
What was the aggregate dollar amount of the unregistered equity sales?
The filing does not disclose the aggregate dollar amount of the unregistered equity sales.
What are the 'Other Events' reported by BioCardia?
The filing lists 'Other Events' as an item information category but does not detail what those events are.
When was the report filed?
The report was filed on April 23, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2025 regarding BioCardia, Inc. (BCDA).